Medicare Drug Plan Prices are Higher than Medicare Drug Card Prices

Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
Report Length
9 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Found Using Methodology
Idependent Author(s)
Brief Executive Summary
The Special Investigation Division of the House Committee on Government Reform investigated the Medicare drug cards, a program created as a transition to the new Medicare prescription drug plans. The investigation discovered the prices from the new Medicare drug plans are significantly higher, averaging 14% more than the drug card prices. The report suggests that the new Medicare drug plans are not successful in negotiating drug price concessions indicating a potential disadvantage for seniors, individuals with disabilities, and taxpayers.
Press Releases and Contextual Information
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views